Tyler Bold
Leader · University of Minnesota Institute on Infectious Diseases
Credentials: · · · · · ·
History
- Present
- Present
- Present
- 2009–2013
Research
Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis
Nature Cardiovascular Research · 2023 · 159 citations
Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
The Journal of Immunology · 2021 · 135 citations
PLoS Pathogens · 2011 · First of 4 authors · 127 citations
135 papers
135 papers
135 papers
- EB
135 papers · 133 as a resident
135 papers · 125 as a resident
- IN
135 papers
- KD
135 papers
135 papers
Grants
- 2025–2029
Mechanisms of CD4 T Cell Help to Myeloid Cells in Tuberculosis
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.9M · University of Minnesota
- 2023–2028
Harnessing Activated CD4 T Cells to Define New Mechanisms of Protection in Tuberculosis
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.4M · University of Minnesota
- 2021–2026
Determinants of Antigen Specific CD4 T Cell Function in Tuberculosis
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $1M · University of Minnesota
- 2009–2011
Initiation and Maintenance of Adaptive Immunity to Mycobacterium Tuberculosis
National Heart, Lung, and Blood Institute · F30
Contact PI · $85.8K · New York University School of Medicine